ROCKET PHARMACEUTICALS INC shareholders Q3 2023

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.

ROCKET PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
COMERICA BANK 440,076$9,017,1570.05%
PROFUND ADVISORS LLC 40,861$837,2420.05%
WELLINGTON MANAGEMENT GROUP LLP 8,022,830$164,387,7870.03%
PUTNAM INVESTMENTS LLC 999,249$20,474,6120.03%
Jump Financial, LLC 39,463$808,5970.03%
Russell Investments Group, Ltd. 728,409$14,925,0990.03%
Rafferty Asset Management, LLC 241,642$4,951,2450.03%
Avior Wealth Management, LLC 17,767$364,0450.02%
Caption Management, LLC 75,000$1,536,7500.02%
Yarbrough Capital, LLC 19,531$400,1900.02%
TWO SIGMA INVESTMENTS, LP 396,339$8,120,9860.02%
SYNOVUS FINANCIAL CORP 84,681$1,735,1130.02%
Sigma Planning Corp 25,780$528,2320.02%
SG Americas Securities, LLC 81,947$1,6790.02%
E Fund Management Co., Ltd. 12,412$2540.02%
Mirae Asset Global Investments Co., Ltd. 387,704$7,944,0550.02%
WCM INVESTMENT MANAGEMENT, LLC 288,801$5,888,6520.02%
Dana Investment Advisors, Inc. 15,409$315,7300.02%
Annandale Capital, LLC 3,220$660.02%
BOOTHBAY FUND MANAGEMENT, LLC 30,200$618,7980.02%
External links

This page lists ROCKET PHARMACEUTICALS INC's shareholders in Q3 2023. To view ROCKET PHARMACEUTICALS INC's shareholder history, click here.